IL-33 up-regulates glucose transporter 1 (GLUT1) expression in NSCLC through activation of the ST2 pathway, thereby enhancing glucose uptake and glycolysis and promoting the growth and metastasis of lung cancer cells [13]. This evidence concerns the gene IL33 and lung carcinoma.